Latest Commercial Agreements News

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Carnaby Resources has completed its acquisition of the Trekelano mining leases, advancing exploration and integration efforts within its Greater Duchess Copper Gold Project.

Amaero Ltd reported a 470% revenue surge to $3.8 million for FY2025, driven by expanded production capacity and exclusive supply deals, while continuing to invest heavily in infrastructure and operations, resulting in a $24.4 million loss.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.

The a2 Milk Company reported record FY25 results with $1.9 billion in sales and declared its first-ever dividends, while advancing a major supply chain overhaul through a key New Zealand manufacturing acquisition and divestment.

Hazer Group has filed patents for a breakthrough graphite purification process that could unlock access to the lucrative battery materials market amid tightening global supply. This innovation positions Hazer to meet surging demand for high-purity graphite essential for lithium-ion batteries.

Nordic Resources has appointed Henrik Grind, a seasoned mining executive with 35 years of experience in Finland and Sweden, as Country Manager to accelerate its gold and nickel-copper projects. This strategic hire coincides with the commencement of a key drill campaign at the Kopsa gold-copper project.

Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.

Green Technology Metals (GT1) and EcoPro Innovation have successfully produced battery-grade lithium hydroxide monohydrate from spodumene concentrate sourced from GT1’s Seymour project in Ontario, confirming high lithium recovery and low impurities.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.